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Abstract
Changes in tissue homeostasis, acquisition of invasive cell characteristics, and tumor formation can often be linked to the
loss of epithelial cell polarity. In carcinogenesis, the grade of neoplasia correlates with impaired cell polarity. In Drosophila,
lethal giant larvae (lgl), discs large (dlg), and scribble, which are components of the epithelial apico-basal cell polarity
machinery, act as tumor suppressors, and orthologs of this evolutionary conserved pathway are lost in human carcinoma
with high frequency. However, a mechanistic link between neoplasia and vertebrate orthologs of these tumor-suppressor
genes remains to be fully explored at the organismal level. Here, we show that the pen/lgl2 mutant phenotype shares two
key cellular and molecular features of mammalian malignancy: cell autonomous epidermal neoplasia and epithelial-to-
mesenchymal-transition (EMT) of basal epidermal cells including the differential expression of several regulators of EMT.
Further, we found that epidermal neoplasia and EMT in pen/lgl2 mutant epidermal cells is promoted by ErbB signalling, a
pathway of high significance in human carcinomas. Intriguingly, EMT in the pen/lgl2 mutant is facilitated specifically by
ErbB2 mediated E-cadherin mislocalization and not via canonical snail–dependent down-regulation of E-cadherin
expression. Our data reveal that pen/lgl2 functions as a tumor suppressor gene in vertebrates, establishing zebrafish
pen/lgl2 mutants as a valuable cancer model.
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Introduction
Tumor suppression is a concept first formulated in Drosophila after
emerging evidence that recessive mutations can lead to the
formation of cellular overgrowth [1,2]. To date, more than 50
tumor suppressor genes have been identified in Drosophila [3]. Their
deficiencies result in benign hyperplasias to malignant neoplasms.
Amongst these tumor suppressors, mutations in lethal giant larvae (lgl),
cause malignant neoplasias in imaginal discs and the brain when
transplanted into wild type adult host flies [4,5]. In Drosophila
neuroblasts, lgl function is essential for localization of the cell fate
determinant Numb, mislocalization of which in lgl mutant larvae
preventstheneuroblastsfromdividingasymmetricallyandtherefore
causes neuroblastoma [6–9]. Furthermore, it has been proposed
that lgl prevents tumor formation by antagonizing the activation of
Dpp signaling by semaphorin 5c in the brain [10]. Although
epithelial overgrowth phenotypes have been reported in lgl mutant
larvae in Drosophila [1], the mechanism by which lgl manifests its
effects on epithelial growth remains to be understood. Nevertheless,
it is known that along with lgl, two other tumor suppressor genes,
discs large (dlg) and scribble (scrib), primarily act in the maintenance
of apico-basal cell polarity in epithelial cells [11].
The establishment as well as the maintenance of apico-basal cell
polarity and eventually the depolarization of a cell is a complex
process, involving several factors. In recent years, a conserved
mechanism for the establishment and maintenance of apico-basal
cell polarization has emerged, which mainly involves two pathways.
Accordingly, the formation of the apical domain is controlled by the
Par (partitioning defective) pathway, which consists of the PDZ
domain containing proteins Par3, Par6, and atypical protein kinase
C (aPKC). In contrast, a pathway consisting of disc-large (dlg), scribble
(scrib) and lethal giant larvae (lgl) regulates the formation and
maintenance of the baso-lateral domain [12,13]. Intriguingly, only
mutations in genes that act in the baso-lateral pathway (e.g. lgl, dlg,
scrib) lead to a neoplastic growth phenotype in Drosophila [2,14–16].
The two vertebrate orthologs of the Drosophila lethal giant larvae gene
have conserved functions in the maintenance of cell polarity and
tissue homeostasis. Disruption of lgl1 function results in the loss of
apical junctional complex in neuroblasts and hyperplasia of the brain
in mouse [17]. Furthermore, it has been shown for human melanoma
cell lines, that a human homolog of lgl, hugl1 is significantly down-
regulated. Artificial induction of hugl1 in these cell lines reduces their
migratory potential with concomitant transcriptional up-regulation of
the cell adhesion molecule E-cadherin (E-cad) and a down-regulation
of matrix-metalloproteinases (mmps), both of which are known to be
involved in suppression of epithelial-to-mesenchymal transition
(EMT), a process which enables an epithelial cell to gain
mesenchymal or migratory properties [18]. Recently, a significant
correlation between the loss of hugl1 and a poor clinical prognosis for
cancer patients has been shown [19].
The forward genetic approach in zebrafish has revealed a novel
function for the second lgl ortholog, pen/lgl2, in maintenance of the
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deficiency primarily results in the loss of hemidesmosomes, cellular
junctions that mediate cell-matrix adhesion [20]. It has been
shown that Lgl2 localizes to the lateral domain of the epidermal
cells and regulates hemidesmosome formation by mediating the
targeting of ITGa6, a component of hemidesmosomes, to the
membrane [21]. Furthermore, epithelial cells in the pen/lgl2
mutant exhibit altered epidermal cell morphology as well as cell
polarity and enhanced epidermal growth [20,21]. Recently, it has
been shown that in colorectal and breast carcinoma cell lines, a
member of the ZFH family of repressors ZEB1 regulates the levels
of Lgl2. The loss of ZEB1 function restores Lgl2 levels and the
epithelial phenotypes in tumor cells, which suggests that Lgl2 acts
as an effector of ZEB1 in tumor suppression [22].
From the analysis of several cancer models it is evident that
autocrine self-stimulation with growth factors is one of the
hallmarks of tumorigenicity [23,24]. However, whether activation
of growth factor signaling is a consequence of the loss of baso-
lateral pathway components remains unclear to date. Moreover,
whether lgl1 and lgl2 deficient clonal cell populations can promote
tumor formation in vertebrate tissues, a typical characteristic of
tumor suppressor genes, remains unresolved. Here, we show that
lgl2 deficient clones indeed promote tumor formation in the
zebrafish epidermis. Moreover, pen/lgl2 mutant basal epidermal
cells undergo EMT. Using biochemical analysis, chemical
inhibitors and genetic interaction studies, we demonstrate that
these phenotypes are a consequence of an over-activation of erbB
signaling involving at least one erbB family member, erbB2. Our
microarray and immuno-histological analysis reveal that activation
of erbB signaling facilitates EMT by transcriptional up-regulation
of key EMT regulators and a reduction in the membrane
localization of E-cad, a known suppressor of EMT.
Results
lgl2 functions as a tumor suppressor gene in the
zebrafish epidermis
We have previously shown that zebrafish pen/lgl2 larvae show
overgrowth of epidermal cells (Figure 1A and 1B; and [20]). As
pen/lgl2 mutant larvae die at 4–5 days post fertilization (dpf), it was
not clear whether these hyper-proliferating cells would be able to
form tumor like structures. To test this, we transplanted cells from
pen/lgl2 homozygous mutant donor individuals, into wild type
Author Summary
In metazoans, the body surface and linings of several
organs are formed from membranous tissue called
epithelia. The functions of epithelia include secretion,
absorption, and protection. Epithelial cells exhibit polar-
ized distribution of several proteins, which is essential for
their function. In carcinomas, which are cancers of
epithelial origin, this epithelial cell polarity is impaired.
Intriguingly, defects in cell polarization can also lead to
tumorigenesis in some animal model systems. It is thus
important to understand how cell polarization and
epithelial growth control are linked so as to treat the
carcinomas better by identifying new drug targets. Here
we show that in zebrafish a gene named lethal giant larvae
2 (lgl2), which is essential for the establishment of
epithelial cell polarity, also acts as a suppressor of
malignant growth properties in the epidermis, an epithelial
component of the skin. We further show that in absence of
lgl2 function increased epidermal growth factor receptor
activity imparts malignant properties to the epidermal
cells. Thus, we report here a mechanism by which
epithelial cells acquire malignant characteristics when cell
polarity is impaired in absence of lgl2 function.
Figure 1. pen/lgl2 deficient epidermal cells form tumors in a cell autonomous fashion. DIC images of 5-day-old wild-type (A) and pen/lgl2
mutant larvae (B). DIC image of wt host with pen/lgl2 mutant skin clones (C). Close-up of a tumor in DIC (D) and GFP channel (E). In comparison to
5 day wild-type larvae (A) the pen/lgl2 mutant larvae exhibit neoplasias, most prominently in the ventral jaw region (B). Seven days after the
transplantation of pen/lgl2 mutant cells at blastula stage, recipients develop tumor like structures in the skin (C). These tumor like structures (D)
contain GFP labelled cells (E) indicating that they are derived from mutant clones.
doi:10.1371/journal.pgen.1000720.g001
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wild type recipients, donor embryos were transgenic for ubiqui-
tously expressed GFP. The recipient larvae with epidermal cells
from mutants or wild type siblings were monitored for potential
tumor development. On the 7th day after the transplantation, 17
of the 24 (71%) larvae that had received pen/lgl2 deficient cells
(GFP marked) in the epidermis developed epidermal tumors
(Figure 1C and 1D). In contrast, none of the larvae that had
received cells from wild type siblings developed epidermal tumors
(n=77). Fluorescence microscopic analysis of these tumors
revealed that they contain GFP positive cells, indicating that the
lgl2
2/2 cells are inducing the formation of epidermal tumors
(Figure 1E). Interestingly, lgl2
2/2 cells in other tissues, including
brain, did not show any visible hyperplasia at this stage. We
conclude that pen/lgl2 mutant cells are capable of inducing
epidermal tumor formation, even if surrounded by wild type tissue.
The levels of GFP expression varied in the tumor cells (Figure 1E).
This may reflect a variegated expression of GFP. However, we
cannot rule out the possibility that some wild type cells also
contribute to the neoplastic tissue. Our results support the notion
that lgl2 acts as a tumor suppressor gene specifically in the
epidermis.
Loss of pen/lgl2 function results in EMT of basal
epidermal cells
Along with uncontrolled cell proliferation, migratory behavior
mediated by EMT is another hallmark of cancer cells [25]. In pen/
lgl2 mutant larvae, epidermal cells not only hyper proliferate but
also exhibit different morphological shape as evident from the
changes in the keratin organization from basal polygonal in wild
type to peri-nuclear and spindle shaped in pen/lgl2 mutants
(Figure 2A and 2B, [20]). Such alterations in cell morphology are
indicative of EMT. Since E-cad membrane levels are inversely
correlated with acquisition of EMT [26–28], we investigated the
localization of E-cad in pen/lgl2 mutants. We found that the
membrane localization of E-cad was severely reduced in the
mutant epidermis, while the cytoplasmic fraction appeared to be
increased compared to the wild type siblings (Figure 2C and 2D).
To observe the behavior of basal epidermal cells of pen/lgl2
mutants, we generated a transgenic line driving the expression of
GFP in basal epidermal cells under the control of DN-p63
promoter [29]. Accordingly, tg(DN-p63::Gal4,UAS::GFP) zebrafish
larvae show GFP expression exclusively in this cell type (Figure
S1). To test whether pen/lgl2 mutant cells acquire migratory
properties, we performed time lapse studies of tg(DN-p63::
Gal4,UAS::GFP);lgl2
2/2 larvae. These revealed that, in contrast
to their wild type siblings, basal epidermal cells in pen/lgl2 mutant
larvae dramatically alter their shape, form numerous lamellipodia
like structures and exhibit net displacement over time (Figure 2
and Videos S1, S2, S3, S4). From an apical perspective, the
observed changes in cell morphology also lead to an increase
in average cell area (Figure 2G). The mutant epidermal cells
appear larger when compared to wild type cells as they exhibit a
highly flattened morphology and develop lamellipodia like cell
protrusions.
We conclude that in absence of pen/lgl2 function the basal
epidermal cells lose their epithelial morphology and acquire the
morphology of migratory (mesenchymal) cells indicating that these
cells undergo the morphological changes associated with EMT.
Expression profile of pen/lgl2 mutant larvae reveals
differential transcriptional regulation of known molecular
regulators of EMT
To understand if pen/lgl2 mutants also show molecular
signatures of EMT and if so, which of the known EMT related
genes are active in pen/lgl2 mutant basal epidermal cells, we
performed a genome wide expression profiling of pen/lgl2 mutant
larvae showing neoplastic overgrowth at 108hpf using the Agilent
Figure 2. Epidermal cells undergo EMT in pen/lgl2 mutant larvae. Basal epidermal cells of wild type and pen/lgl2 mutant 5dpf stained using
pan 1–8 Cytokeratin antibody (Ai - Bii) and E-cad antibody (C, D). Time lapse analysis of tg(DNp63::Gal4,UAS::GFP) labelled cells in wild-type (E) and
pen/lgl2 mutant larvae (F) at 5dpf. Analysis of cell area in wild-type and pen/lgl2 mutant larvae (G). In contrast to wild-type larvae (Ai, Aii), in pen/lgl2
mutant larvae the cells appear spindle shaped with keratin accumulation around the nucleus (Bi, Bii). Furthermore, in wild-type basal epidermal cells
(C), E-cad localizes to the cell membrane; cells exhibit perfect polygonal shapes. In pen/lgl2 mutant larvae (D) membrane localization of E-cad is
strongly reduced with concomitant increase in the cytoplasmic fraction. Time-lapse analysis reveals (E, F) that there is no change in the shapes of
wild-type epidermal cells (E). However, in pen/lgl2 mutants (F) the shape of epidermal cells dramatically changes over time, indicating their
metastable cell fate. Cells develop lamellipodia like structures, a classic trait exhibited by mesenchymal cell types (see Videos S1, S2, S3, S4 in
addition). As epidermal basal cells flatten and develop lamellipodia like cell protrusions in pen/lgl2, the cell area in apical view is increased in these
larvae (G). However, average area of epidermal basal cells in these mutants is highly variable compared to wild types.
doi:10.1371/journal.pgen.1000720.g002
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genes to be significantly differentially regulated in pen/lgl2 mutant
larvae (FDR; P#10
26) (Figure 3A and Table S1). Amongst these
differentially regulated genes, we found a very strong transcrip-
tional induction of mmps such as mmp9 (11.1 fold) and mmp13 (3.1
fold), which are known regulators of EMT, mainly in the context
of malignancy [30–32]. Further, we found a set of cytokeratins, krt5,
ckrt1, ckrt2, and collagens to be down-regulated within a range of
3.5 to 4.4 fold, which is consistent with the previous analysis of the
role of cytokeratins in EMT [28]. Moreover, genes involved in cell
cycle regulation (e.g. histone-b, jun-b, N-ras), cell survival (e.g.
sgk1) and tight-junction formation (e.g. cldn-7, cldn-e, cldn-c, cldn-i)
were also up-regulated from 3.6 to 5.6 fold (Figure 3A).
The canonical way to achieve EMT is to down-regulate E-cad at
the transcriptional level. The transcriptional repressors, mainly
those of the snail family, play an important role in this process
[27,33–35]. Intriguingly, we observed robust up-regulation of E-
cad expression at the mRNA level (Figure 3A). By performing
quantitative RT-PCR in pen/lgl2 mutant larvae, we detected 8
times higher E-cad RNA levels in mutants compared to the wild
type sibling controls (Figure 3B). Further, examination of E-cad by
western blot analysis revealed increase in protein levels in pen/lgl2
mutant larvae compared to their wild type siblings (data not
shown). Thus, although the membrane localization is drastically
perturbed (Figure 2C and 2D), E-cad protein levels are higher in
pen/lgl2 mutants. We further estimated the expression levels of snail
family members. Consistent with up-regulation of E-cad levels,
none of the snail family members shows increased expression in
pen/lgl2 mutants. These data indicate that in pen/lgl2 mutant larvae
EMT of basal epidermal cells is facilitated by mis-localizing E-cad
rather than its snail mediated repression.
Weconfirmedthetissue specificityofdifferentialexpressionofthe
genes mmp9, sgk1, cldn7, krt5 and E-cad by in-situ hybridization (ISH)
(Figure 3C–3L). We verified the up-regulation of mmp9 as well as
sgk1 and down-regulation of krt5 specifically in the basal epidermal
cells. Interestingly, the up-regulation of the tight-junction gene cldn7
was observed mainly in the cells that form epidermal cell aggregates
in the ventral jaw region and in the fin-fold (Figure 3H).
Our analyses indicate that basal epidermal cells in pen/lgl2
larvae exhibit both the morphological and transcriptional
characteristics of cells undergoing EMT. We conclude that pen/
lgl2 function is essential to suppress epidermal neoplasia and EMT.
Thus, pen/lgl2 acts as a recessive tumor suppressor gene in
vertebrates. Furthermore, canonical snail mediated repression of
E-cad is not involved in EMT in pen/lgl2 mutant. Instead, EMT is
facilitated by removal of E-cad from the plasma membrane.
Figure 3. pen/lgl2 mutant epidermal cells differentially express EMT regulators. Graphical representation of expression data of some of the
relevant genes obtained by microarray (A) and quantitative RT-PCR (B). RNA In situ hybridization analysis in wild-type (C, E, G, I, K) and pen/lgl2 mutant
larvae (D, F, H, J, L) at 5dpf. Gene expression data obtained by microarray analysis reveals strong transcriptional activation of EMT associated matrix
metalloproteinases like mmp9 and mmp13, cell-cycle related genes like proto-oncogene jun-b and histone 2b, whereas expression of cytokeratins like
krt5 or cyt1 is decreased. Interestingly, tight junction proteins cldn7, cldne as well as adherens junction component E-cad and serum- and
glucocorticoid-induced kinase-1 (sgk1) were also up-regulated in pen/lgl2 mutant. RT-PCR analysis (B) revealed that E-cad expression is indeed
significantly up-regulated in mutant larvae with marginal decrease in snail expression levels. In situ hybridization analysis (C–L) reveals that the
relevant genes are differentially expressed in the epidermis. Note that cldn7 is highly up-regulated in the cellular clumps in the finfold (arrows in H).
**=P,0.005
doi:10.1371/journal.pgen.1000720.g003
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and EMT in basal epidermal cells of pen/lgl2 mutant
larvae
As human carcinomas are often a consequence of massive over
activation of growth factor signaling [36], we assayed pen/lgl2
mutant larvae for the phosphorylation level of the mitogen
activated protein kinase Erk, a common member of growth factor
signaling cascades, by western blot [37]. We found elevated levels
of phosphorylated Erk in the mutants compared to their wild type
siblings (Figure 4A). To identify which growth factor signaling is
activated, we treated larvae from heterozygous pen/lgl2 carriers
with inhibitors for three different receptor tyrosine kinases (RTKs),
FGFR, IGFR and EGFR, starting at 96 hpf just prior to the
appearance of the pen/lgl2 mutant phenotype. These treatments
revealed that an inhibitor of ErbB (PD168393) reduced the levels
of phosphorylated Erk (Figure 4B) and rescued the epidermal
neoplasia phenotype as well (Figure 4D and 4E). Similar rescue in
the epidermal phenotype was observed with another ErbB
inhibitor AG1478 (data not shown). In contrast, Inhibition of
FGFR (SU5402) neither affected the levels of phosphorylated Erk
(Figure 4C) nor did it rescue the epidermal overgrowth phenotype
(data not shown). Similarly, there was no rescue in the epidermal
overgrowth phenotype when IGFR signaling was inhibited using
AG1024 (data not shown). Genotyping of an entire clutch treated
with ErbB inhibitor (PD168393) revealed the expected Mendelian
proportion (27 out of 120) of pen/lgl2 homozygous larvae. We
further asked whether the EMT and over-proliferation phenotypes
were suppressed after treatment with PD168393. Indeed,
cytokeratin and E-cad antibody stainings of inhibitor treated
pen/lgl2 mutant larvae were indistinguishable from wild type
siblings (Figure 4H and 4K). Consistently, epidermal cell
proliferation and mmp9 transcript levels were strongly reduced
(Figure 4L–4N, Figure 4O–4Q). However, hemidesmosomes did
not form in PD168393 treated pen/lgl2 mutant larvae as revealed
by electron microscopic analysis (Figure S4).
Our data indicate that loss of functional pen/lgl2 results in over
activation of ErbB signaling which promotes over proliferation of
basal epidermal cells as well as cellular EMT by transcriptional
modulation of EMT regulators. We further conclude that over-
activation of ErbB signaling is not the cause for the absence of
hemidesmosomes in the pen/lgl2 mutant. This observation further
indicates that disruption of pen/lgl2 primarily affects hemidesmo-
some formation, which is consistent with the previous analysis
[20,21].
erbB2 promotes EMT but not the cell proliferation in the
basal epidermal cells of pen/lgl2 mutant larvae
In mammals four ErbB receptors are known, ErbB1 to ErbB4,
which get activated upon the binding of ligands such as EGF, HB-
EGF, neuregulins, betacellulin [38]. Ligand binding leads to the
formation of homo- or heterodimers amongst these receptors,
resulting in signal transduction [38]). Our bioinformatic and
phylogenetic analysis coupled with the previous analysis of some of
the family members [39,40] revealed that with the exception of
erbB2, all other members of this family exist in duplicates in the
zebrafish (Figure 5A). erbB2 as well as pcs/erbB3b zebrafish mutants
exhibit defects in glia development and regeneration [39–42]. We
found erbB2 to have an additional epidermal phenotype in the fin-
fold (Figure 5C) and it is also expressed in the epidermis
(Figure 5E). To determine which of the ErbB receptors is activated
in pen/lgl2, we performed loss of function studies in a pen/lgl2
mutant background. We knocked down erbB1a with a splice site
antisense morpholino. Injections of erbB1a morpholino did not
interfere with the pen/lgl2 phenotype but reproduced the
cardiovascular phenotype published earlier [43] (data not shown).
However, we cannot exclude the involvement of erbB1a in
promoting the EMT and growth phenotype in pen/lgl2 mutant
larvae as we found the effect of the morpholino to decrease beyond
48hpf, possibly due to dilution effects (Figure S2). Double mutants
of pcs/erbB3b
2/2,pen/lgl2
2/2 genotype did not show suppression
of the pen/lgl2 neoplastic phenotype and immuno-histological
analysis using the pan 1–8 Cytokeratin antibody did not reveal any
reduction in strength and initiation of EMT phenotype (data not
shown, Figure 5I). Taken together, these results demonstrate that
erbB3b function is not essential for neoplasia and EMT phenotype
in pen/lgl2 mutants.
In zebrafish, lgl2 and erbB2 are both located on chromosome 12
(23.6mb distance). To study double mutants, chromosomal
recombinants were made (see Materials and Methods). We
investigated progeny from lgl2
2/+, erbB2
2/+ double heterozygous
fish (3 crosses; n=296), which were sorted for the morphological
epidermal lgl2 phenotype at 108hpf as well as 132hpf and
subsequently genotyped. We identified 40 larvae that were
homozygous for both lgl and erbB2. In 37 of these, no epidermal
phenotype was detected up to 132hpf (Figure 6C). In contrast, all
lgl2 larvae with erbB2
+/2 or erbB2
+/+ genotype showed strong
phenotypes or lethality at the same stage (Figure 6B, Table S2). In
a separate experiment, we analyzed Cytokeratin and E-cadherin
localization, mmp9 expression and BrdU incorporation in lgl2
2/2,
erbB2
2/2 double mutants at 108hpf when the lgl2 phenotype
becomes apparent. The morphology of the epidermal cells in the
double mutant larvae, as revealed by Keratin staining, appeared
completely normal at 108hpf Figure 6D–6F). Occasionally,
epidermal cells in pen/lgl2; erbB2 double mutant larvae exhibited
milder changes in Keratin organization, indicative of altered
cellular morphology at 132 hpf (data not shown). E-cadherin
localization appeared normal in the epidermis of the double
mutants (Figure 6G–6I) and mmp9 expression levels in the
epidermis of double mutant larvae were comparable to those in
wild type (Figure 6M–6O). Interestingly, however, the BrdU
incorporation analysis revealed that (Figure 6J–6L) there is no
significant decrease (t-test, p.0.05) in the epidermal cell
proliferation in a predefined area in lgl2
2/2,erbB2
2/2 double




Our data suggest that erbB2 but not erbB3b mediated signaling is
responsible mainly for the EMT phenotype in pen/lgl2 mutant
basal epidermis. We did not observe rescue in the epidermal cell-
proliferation phenotype in pen/lgl2; erbB2 double mutants and
epideramal cell morphology was altered as well at later stages
indicating that erbB2 deficiency doesn’t completely rescue the
phenotype. Since the inhibitors completely rescue both the
proliferation as well as EMT phenotypes, we propose that other
ErbB receptors might be involved in promoting epidermal cell-
proliferation in pen/lgl2 mutants.
Discussion
Impaired cell polarity is one of the hallmarks of carcinoma but
was considered to be a secondary effect for a long time. Recent
findings however suggest it can also be a cause rather than a
consequence of tumor progression [18,19,44,45]. In many
epithelia, the apico-basal polarity is established by the activity of
the apical aPKC-Par3-Par6 pathway and baso-lateral Lgl-Scrib-
Dlg pathway. Surprisingly, only loss of function in baso-lateral
pathway components leads to epithelial or brain neoplasia
phenotypes in Drosophila [45]. In vertebrates, two components of
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PLoS Genetics | www.plosgenetics.org 5 November 2009 | Volume 5 | Issue 11 | e1000720Figure 4. Inhibition of ErbB signaling restores the epidermal morphology and cell cycle in pen/lgl2 mutant larvae. Western blot
analysis of Erk1/2 phosphorylation in untreated wild-type and pen/lgl2 larvae (A), larvae treated with PD168393 (B) and larvae treated with SU5402 (C).
DIC images of wild-type (D) and pen/lgl2 mutant (E) treated with the ErbB inhibitor PD168393 and genotyped. The pan 1–8 cytokeratin antibody
staining (F–H), anti E-cad staining (I–K), anti BrdU antibody staining (L–N) and in situ hybridization staining for mmp9 (O–Q) of the epidermis of wild-
type (F, I, L, O) pen/lgl2 mutant (G, J, M, P) and mutant larvae treated with PD168393 (H, K, N, Q). In comparison to wild-type larvae (A, left lane, 44kD)
Erk shows higher level of phosphorylation in pen/lgl2 mutant larvae (A, right lane 44kD). The levels of Erk phosphorylation are equal in the mutants
treated with PD168393 (B) but not with SU5402 (C). The a-Tubulin levels (55kD) are indicative of equal protein loading. The epidermal cell
morphology, E-cad localization, cell proliferation and mmp9 expression in pen/lgl2 larvae, treated with PD168393 (H, K, N, Q) appears similar to wild-
type larvae (F, I, L, O) than the untreated mutant larvae (G, J, M, P). Note that PD168393 treated (rescued) larvae were genotyped to confirm their
genotypes.
doi:10.1371/journal.pgen.1000720.g004
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lgl1 function results in brain hyperplasia in the mouse [17]. In
zebrafish loss of lgl2 function leads to over-proliferation of
epidermal cells [20]. Here, we demonstrate that transplantation
of pen/lgl2 homozygous mutant cells during blastula stage into wild
type embryos results in the formation of tumor like structures in
the epidermis after 7 days. This analysis clearly shows that lgl2
behaves as a tumor suppressor gene in vertebrates.
The basal epidermal cells in pen/lgl2 mutants do not form
hemidesmosomes and display an altered cell morphology instead
of the polygonal cell shape found in wild type larvae [20]. E-cad
localization at the plasma membrane is reduced in the mutant
epidermal cells indicating that epidermal cells undergo EMT.
Indeed, GFP labeling of basal epidermal cells revealed that in pen/
lgl2 mutant larvae these cells show continuous changes in their
morphology, project lamellipodia and move as a sheet. This sheet
like movement has been described as a metastable cell state in the
context of EMT [28]. Consistent with the cellular analysis, the
expression profiling of lgl2 mutant basal epidermal cells revealed
differential expression of the known EMT markers and regulators
such as matrix-metalloproteinases and keratins. Intriguingly, the levels of
E-cad RNA are high in the pen/lgl2 mutant. This is in contrast to
known developmental scenarios of EMT such as the delamination
of neural crest cells or gastrulation where E-cad expression is
downregulated at the transcriptional level by a transcriptional
repressor, snail [34,35]. In addition, structural components of tight
junctions, such as several claudins, are also up-regulated in pen/lgl2
mutants. Thus, the expression profiles of cell adhesion molecules
in pen/lgl2 larvae resemble several human breast carcinomas
including an inflammatory breast cancer (IBC), a highly aggressive
subtype of human breast cancer, which has been characterized by
E-cad and erbB2 over-expression [46–51]. The up-regulation of
claudin genes is intriguing. However, it is not clear whether Claudins
localize properly in the epidermal cells. Even if the Claudins do
localize properly, the in-situ expression analysis suggests that
claudins are up-regulated mostly in the cellular clumps that are
formed in the median finfold or in the ventral jaw region. It is thus
clear that claudins are not expressed during the process or EMT
but rather when the mesenchymal cells re-acquire partial epithelial
phenotypes while forming tumor like aggregation. However,
further analysis is required to test this notion.
How does deficiency in components of the baso-lateral pathway
lead to epithelial cell proliferation and EMT? It has been
suggested that the protein Scrib stabilizes the coupling between
E-cad and the Catenins and thus behaves as a regulator of
epithelial cell adhesion and migration [52]. Our data show that for
Lgl2 the mechanism to suppress EMT and tumor formation is
fundamentally different. Lgl2 may not manifest its function by
stabilizing the coupling between E-cad and Catenins. Previously,
we have shown that neither the loss of maternal nor zygotic lgl2
function primarily affect E-cad localization [20,21]. Consistent
with mammalian data, knockout of E-cad in the mouse or zebrafish
epidermis does not result in EMT [21,53–55]. This indicates that
although the loss of E-cad facilitates EMT [56], it may not be
sufficient to induce it in animal models.
We show that inhibition of erbB2 signaling, either genetically or
by small chemical inhibitors, leads to suppression of EMT and a
neoplastic phenotype in pen/lgl2 mutant larvae. Intriguingly, E-cad
membrane localization is restored in these larvae, indicating that
the loss of E-cad is a consequence of activation of ErbB signaling
rather than a cause of it. Thus, our analyses presented here suggest
that Lgl2 acts as a tumor suppressor by regulating the amplitude of
ErbB signaling in the epidermis. Since we did not observe snail-
mediated down-regulation of E-cad, we propose that an erbB2
dependent pathway in pen/lgl2 mutants leads to the destabilization
of E-cad at adherens junctions. Indeed in pen/lgl2 mutant
epidermal cells, known modifiers of E-cad function, such as
mmp9 and sgk1 are up-regulated (Figure 3). While Mmps are
known to be involved in ecto-domain shedding of E-cad [57,58],
Sgk1 functions in the phosphorylation of Ndrg1, a protein
involved in vesicular recycling of E-cad [59,60]. Additionally,
recently published data from cell culture suggests an involvement
of RTK signaling in the destabilization of adherens junctions via
Numb [61]. Here, Numb functions as an adapter protein coupling
Figure 5. Phylogenetic analysis of erbB family members and zebrafish mutants of erbB paralogs. (A) Phylogenetic analysis of erbB family
members in the zebrafish genome (zv7) with the human orthologs (Minimum evolution algorithm, 100 replicates). With the exception of erbB2, all
other erbB family members are duplicated in zebrafish. (B–D) DIC Images of wild-type (B), erbB2
2/2 (C) and erbB3b
2/2 (D) larvae at 132hpf. (E) In-situ
hybridization analysis of erbB2 at 48hpf. Keratin staining in erbB3b mutant larva (F) erbB3b/lgl2 double mutant larva (G) and pen/lgl2 mutant larva (H)
at 132 hpf. Note that in erbB3B;lgl2 double mutants (G) epidermal cells appear spindle shaped as in pen/lgl2 mutant larvae (H). erbB3b (F) mutations
alone do not affect the morphology of basal epidermal cells.
doi:10.1371/journal.pgen.1000720.g005
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PLoS Genetics | www.plosgenetics.org 7 November 2009 | Volume 5 | Issue 11 | e1000720Figure 6. erbB2 promotes EMT in the epidermis of pen/lgl2 mutant larvae. DIC images of the morphology of wild-type (A), lgl2,erbB2
+/2 (B)
and lgl2,erbB2
2/2 (C) larvae at 108hpf. Keratin (D–F), E-cadherin (G–I), BrdU (J–L) and mmp9 (M–O) staining in wild-type (D, G, J, M), lgl2,erbB2
+/2 (E, H,
K, N) and lgl2,erbB2
2/2(F, I, L, O) larvae at 108hpf. The DIC images of the morphology reveals that cellular clumps, a typical characteristic of pen/lgl2
mutant larvae are present in lgl2,erbB2
+/2 (B) but are absent in lgl2,erbB2
2/2(C). The keratin, E-cadherin and mmp9 staining in lgl2,erbB2
2/2 (F, I, O)
appear similar to wild-type (D, G, M) indicating erbb2 promotes the EMT phenotype in pen/lgl2 mutant larvae. Note that, in lgl2,erbB2
2/2 larvae (L)
BrdU incorporation does not decrease to wild-type levels (J).
doi:10.1371/journal.pgen.1000720.g006
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shown to be sensitive to elevated levels of RTK signaling, leading
to mislocalization of E-cadherin [61]. Further analysis involving
loss of function of mmps and sgk1 as well as studies of Numb
localization in the pen/lgl2 mutant larvae would be necessary to
clarify their contributions to the EMT phenotype.
The primary function of Lgl2 in hemidesmosome formation
[20,21] is not dependent on ErbB signaling as hemidesmosomes
do not form in pen/lgl2 mutants even after the inhibition of ErbB
signaling (Figure S4). This suggests that the loss of hemidesmo-
somes might be the cause but not a consequence of the activation
of ErbB signaling. This hypothesis is supported by the fact that
components of hemidesmosomes (e.g. Itga6/Itgb4), physically
interact with the ErbB2 receptor tyrosine kinase [62–64]. Thus, it
is possible that mislocalization of hemidesmosomal components in
pen/lgl2 mutants lead to an activation of ErbB2.
ErbB signaling plays an important role in the development of
human carcinomas, as it is able to induce proliferation and EMT
and further is able to suppress apoptosis [36,65]. This is in
particular true for ErbB2 which is over-expressed in more than
25% of all breast carcinoma [66]. A causal link between ErbB
activation and loss of cell polarity, which is one of the hallmarks of
carcinomas, has recently been established. It has been shown that
activated ErbB2 associates with Par6-aPKC leading to disruption
of the apico-basal polarity [67]. While ErbB2 regulates apico-basal
cell polarity by interacting with apical polarity components like
Par6-aPKC, our analyses presented here suggest that one of the
basolateral pathway components, Lgl2, regulates the activation of
ErbB2. Thus, there seems to be a reciprocal interaction between
cell polarity regulators and ErbB2 signaling. Interestingly,
although ErbB2 activation induces cell proliferation, the associa-
tion of ErbB2 with Par6-aPKC was not essential for regulating cell
proliferation indicating that ErbB2 affect the cell proliferation
independent of disruption of apico-basal cell polarity [67]. Our
data suggest that at the organismal level loss of ErbB2 does not
affect the epidermal cell proliferation phenotype in lgl2 mutants
but only prevents EMT. Since inhibitors, which do not
discriminate between various ErbB family members rescue both,
proliferation as well as EMT phenotypes, it appears that activation
of more than one ErbB family member might be involved in
promoting epidermal neoplasia in pen/lgl2 mutants. Thus, cell
proliferation and EMT phenotypes are not coupled in pen/lgl2
mutant larvae.
The ErbB signaling pathway includes multiple ligands and
receptors in vertebrates. ErbB1 and ErbB4 represent discrete
RTKs, as they contain ligand binding sites as well as a kinase
activity, essential for auto-phosphorylation and signal transduc-
tion. In contrast, ErbB2 and ErbB3 do not independently
transduce extracellular signals as homodimers since ErbB2 has
no ligand-binding domain and ErbB3 has no kinase domain.
Thus, ErbB2 and ErbB3 must interact with each other or with
other ErbB receptors to transduce signals [38]. Analysis of the
Danio rerio genome revealed that genome duplication events have
led to the duplication of erbB1, erbB3 and erbB4 making the
situation even more complex. We found that homozygous
mutations in erbB2 but not erbB3b dramatically rescued the EMT
phenotype, establishing ErbB2 signaling to be responsible for the
onset of EMT. However, the direct activator of ErbB2, in
promoting the EMT phenotype in lgl2 mutants remains
unidentified at this point.
To summarize, lgl2 function is essential for tumor suppression
and EMT in the vertebrate epidermis. pen/lgl2 mutant cells are
able to induce the formation of epidermal tumors when
surrounded by wild type cells. In the absence of Lgl2,
hemidesmosomes do not form and ErbB signaling is activated,
which results in induction of pathways involved in promoting
EMT via mislocalization of E-cad as well as proliferation.
Amongst several erbB paralogues, erbB2 is more directly involved
in transducing the signal. Thus, the pen/lgl2 mutant would serve as
a very good model to perform chemical screens for compounds
that are able to suppress erbB signaling or important downstream




The morphological and immuno-histological analysis of pen/lgl2
mutant was carried out in Tuebingen (TUE) and WIK
background. For transplantations, embryos from pen/lgl2 mutants
in the background of an b-actin::GFP transgenic line were used as
donors and from albino fish as recipients. Live imaging was
performed in transgenic DNp63::Gal4, UAS::GFP line. The erbB2
mutant allele used in this work is st61 [39]. The erbB3b mutant
allele is HJ036, which contains a C to A point mutation at position
156 leading to a premature stop after 50 amino acids [41]. As lgl2
and erbB2 are located on the same linkage group, to generate
double mutants, we crossed pen/lgl2
+/2 fish with erbB2
+/2 fish and
out-crossed the obtained trans-heterozygote F1 fish to albino fish.
The F2 generation were then screened by genotyping for both, the
pen/lgl2 and erbB2 mutations.
Phylogenetic analysis
Protein sequences for ErbB zebrafish paralogues and human
orthologues were obtained from Genebank (http://www.ncbi.nlm.
nih.gov) and through Ensembl (http://www.ensembl.org/Danio_
rerio) databases. Alignments were performed using ClustalW.
Phylogenetic analysis was run using neighbor joining, maximum
parsimony and minimum evolution algorithms, (MEGA4, http://
www.megasoftware.net/). All analysis methods showed similar tree
morphology with comparable bootstrap values (1000 replicates).
Human orthologues (Genebank ID): ERBB1: 1956, ERBB2: 2064,
ERBB3: 2065, ERBB4: 2066. Zebrafish paralogues (Ensembl
transcript ID): erbB1a: ENSDART00000027219, erbB1b: EN-
SDART00000031151, erbB2: ENSDART00000003932, erbB3a:
ENSDART00000014892, erbB3b: ENSDART00000049893, erbB4a:
ENSDART00000092114, erbB4b: ENSDART00000100398
Generating DNp63::Gal4, UAS::GFP transgenic fish
The DNp63 promoter was cloned by enzymatic restriction of
BAC dkey-13d19 with HhaI (NEB) and subsequent blunt-end
cloning of a resulting 4.96 kb fragment into a plasmid containing a
Gal4,UAS::GFP expression cassette and mini-TOL2 sites (based
on [68,69]). Transgenesis was achieved by simultaneous injection
of plasmid DNA and transposase RNA at 1-cell stage using WPI
PV830 pneumatic injection system followed by F1 screen for GFP
positive larvae.
BrdU labelling
5-day-old wild type and pen/lgl2 mutant larvae were incubated
with 10 mM BrdU solution in 2% DMSO in embryonic medium
(E3) for 2 hours. After treatment, larvae were washed several times
in E3 fixed overnight in 4% PFA in PBS at 4uC. Staining was
performed as described below.
Immunohistochemistry
For IHC procedures the following antibodies were used: Anti-
BrdU antibody ab6326 (abcam); anti Cytokeratin antibody Ks pan
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tion Laboratory). Embryos were either fixed in 4% PFA (E-cad,
BrdU) or in Dent’s fixative (cytokeratin). After downgrading the
larvae to 0.1 M phosphate buffer (PB), they were washed with PBT
(PB+0.8% Triton X-100) five times and blocked in 10% normal
goat serum. For BrdU staining, larvae were treated with 4 N HCl
for 20 min., washed in PB and blocked in 1% BSA for 1–3 hours.
Antibodies were diluted as: Ks pan 1–8 (1:10), anti-E-cad (1:250),
anti-BrdU (1:50) and samples were incubated at room temperature
for 4 hours or overnight at 6–8uC. Afterwards, larvae were washed
five times in PBT, incubated with Cy3 or Alexa 488 anti-mouse or
anti-rat antibodies, post fixed in 4% PFA and upgraded in 70%
glycerol for fluorescence/light microscopy.
In situ hybridization
DIG-labeled RNA probes for cldn7, krt5, mmp9 and sgk1 were
prepared from larval 5dpf total cDNA obtained from pen/lgl2
2/2
mutants. In situ hybridization was performed using Intavis in-situ
robot (model: insituPro VSi).
Probe templates have been amplified with the following primer
combinations by PCR reaction and subsequently cloned into
pGEM-T Easy Vector (Promega). DIG-labeled probes were














Transplantations were carried out at blastula stage. After
transplantations, donor and corresponding recipients embryos
were cultured together (3–5 in number) in a 24 well plate. The
pen/lgl2 mutant donors were identified at 4.5dpf by phenotype or
by molecular genotyping at blastula stage (RFLP). The host larvae
that received mutant or wild type clones (GFP-positive) in the skin
were sorted and further raised up to 7–8 dpf and analyzed by
microscopy for tumor phenotypes.
Inhibitor treatment
For screening, all inhibitors (SU5402; AG1024; PD168393;
AG1478 all Calbiochem) were used at 10–50 mM concentration in
1% DMSO in E3 Medium starting at 96hpf. For BrdU, IHC and
ISH experiments, PD168393 and AG1478 were used at a
concentration of 10 mM starting at 96hpf.
Western blot and detection
For western blots, mutants were identified by the development
of the characteristic lgl2 mutant phenotype at 108hpf. Three times
40 mutants and equivalent number of wild type larvae were
collected at 108hpf and than treated with either DMSO as a
control, or inhibitors for ErbB signaling (10 mM) or FGFR
signaling (20 mM) for 12 h. Subsequently, larval tails were
collected by cutting posterior to the swimming bladder on ice.
Proteins were extracted in DXB (25 mM Hepes, pH 6.8, 50 mM
KCl, 1 mM MgCl2, 1 mM DTT, 250 mM sucrose) containing
Roche Complete protease inhibitors (Cat No. 11836153001) and
Pierce Halt phosphatease inhibitors (Cat No. 78420). Protein
concentration was determined using OD at 280 nm (NanoDrop).
For PAGE, NuPage 4–12% gradient gels (Invitrogen) were used.
After transfer, equal loading was re-checked by poinseau red
staining. Antibodies used were: p-ERK (M9692; 1:600), Erk
(M5670; 1:500), a-Tubulin (T9026; 1:10000) (all from Sigma).
Secondary antibodies used were HRP conjugated anti-mouse (p-




The microarray experiment was conducted using tissues (tail)
posterior of the anal opening of wild type (Tuebingen) and pen
larvae at 5 dpf. RNA for microarray analysis was extracted from
four biological replicates using TRIZol Reagent (Gibco BRL,
Eggenstein, Germany). Complementary RNA was prepared from
1 mg total RNA from each replicate as described in the Agilent
Low RNA Input Linear Amplification kit manual (Agilent
Technologies, Palo Alto, CA, USA). Double-stranded cDNA was
synthesized using the reagents from this kit, and Cy3- or Cy5-
labeled cRNA was prepared by cDNA in vitro transcription in the
presence of cyanine 5-CTP or cyanine 3-CTP dyes. Fluorescently
labeled RNA was then purified with the Qiagen RNEasy spin
columns, according to the manufacturer’s protocol (Qiagen,
Hilden, Germany). After purification, cRNA was fragmented
and used to hybridize to the zebrafish G2519F 4X44 microarray
platform containing 4 duplicated arrays of the 22,000 probe-set
design (Agilent Technologies, Palo Alto, CA, USA). Four
biological replicates were conducted, including two dye swap
experiments to minimize the effect of any potential dye bias.
Hybridization, washing, and scanning were performed according
to the manufacturer’s protocol. The microarrays were scanned on
a Genepix Axon 4000B scanner (Molecular Devices, Union City,
CA, USA) at five micron resolution with five-line averaging. Raw
expression values from each probeset were extracted using the
Genepix Pro 6.0 feature extraction software, and features were
flagged manually for poor quality. The data were then analyzed in
the R statistical programming environment using the Bioconduc-
tor module Limma [70,71]. Duplicate probesets on each array
were considered as technical replicates for the analysis in addition
to the 4 biological replicates on separate arrays. A standard linear
model for differential expression, with the Limma module in
Bioconductor, was used to identify genes up and down regulated in
the mutant versus wild type experiment. The resulting p-values
from the hypothesis tests were adjusted for multiple testing with
the false discovery approach (FDR) to control for false positives
[72]. In addition, the empirical Bayes approach automatically
adjusts raw p-values for multiple testing and generates a B-statistic
that may also be used for ranking differentially expressed genes
[70]. All microarray data may be accessed through the ArrayEx-
press repository on the European Bioinformatics Institute database
website (http://www.ebi.ac.uk/microarray-as/ae/).
Quantitative real-time PCR
As for the microarray experiment, larval tails posterior to the
anal opening were used as tissue sample (3 technical replicates of
each biological replicate; 3 biological replicates). Total RNA was
isolated using TRIZOL reagent (Invitrogen) and cDNA was
synthesized using AMV cDNA Synthesis Kit (Invitrogen) with
oligo-dT15 primers (Promega). SYBR Green (BioRad) was used
for quantitative real-time PCR. Time emission readings were
recorded with DNA Engine Opticon 2 (MJ Research), and
analyzed as described [73]. gapdh was used for normalization
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determined using student’s t-test.
Genotyping of mutant larvae
Genotyping to indentify mutants was done by a PCR based
restriction fragment length polymorphism (RFLP) method for lgl2-
and erbB2- or by DNA sequencing for erbB3b mutants. The RFLP
analysis was done as follows- the mutations in erbB2 cause a loss
whereas in lgl2 a gain of a restriction site. PCR product from
genomic DNA samples obtained by the primer pairs: 59-
ATGCATACCTTCCTGGAGTAG-39;5 9-TGTGGTTCTA-
GTGGAGGAGGA-39 (for lgl2)o r5 9-TGAAGAATGCTGG-
TAGCTGG-39 and 59-GGACTCAGCAAAGG ACTTAC-39
(for erbB2) was digested with either SfcI (for lgl2 mutation) or
BsrGI (for erbB2 mutation) resulting in a genotype specific DNA
band pattern (Figure S3). The erbB3b genotyping was done by
scoring for the premature stop at position 156bp by DNA
sequencing of a PCR product obtained from the genomic DNA
using the primer pair 59-CGCTCTCCTGTTCCTCTGTG-39;
59-ACCCTCTTCCTCCATTGTCC-39 (Figure S3). In case of
PFA fixation, individual genomic DNA samples were sampled
before fixation (head tissue). The genotype of larvae used in ISH
experiments was scored by the development of the characteristic
lgl2 phenotype.
Movie processing and image analysis
Time-lapse movies were acquired using AxioVision 4.6 (Zeiss)
and compressed in the Codec H264. For encoding in H264, the
OSS Virtual Dub was used. Cell area (Figure 2G) was determined
using the ‘‘outline’’ tool included in Zeiss AxioVision 4.6 (Zeiss) on
three biological replicates each from wild type and pen/lgl2. Scale
bars indicate equal sizes within one figure.
Supporting Information
Figure S1 Expression of GFP under the DNp63 promoter.
Antibody staining of 5.5dpf tg(DNp63::Gal4,UAS::GFP) zebrafish
larvae using anti Cytokeratin (red) and anti GFP antibody (green).
The co-labeling of both antibodies reveals activity of the 4.96 kb
upstream promoter element of DNp63 exclusively in basal
epidermal cells in the skin.
Found at: doi:10.1371/journal.pgen.1000720.s001 (0.70 MB TIF)
Figure S2 Knockdown of erbB1a using morpholinos. For knock-
down of erbB1a, we used a morpholino targeted to a splice site. To
test the activity of this morpholino over time, primers spanning the
targeted intron-exon boundary were designed. (A) PCR performed
on cDNA from morphant zebrafish larvae at different time points
reveals morpholino efficiency. (B) A working morpholino causes
splice events to fail at the targeted splice site (red) resulting in
larger PCR product. Genomic DNA contamination of the cDNA
causes a third, larger, product as the amplicon spans two introns
on the genomic template. This analysis reveals that the used
morpholino only prevents efficient splicing of erbB1a RNA before
48hpf, causing equal amounts of spliced vs. morphant RNA at




Found at: doi:10.1371/journal.pgen.1000720.s002 (0.54 MB TIF)
Figure S3 Genotyping of lgl2, erbB2,a n derbB3b. The genotype of
larvaepresented inthisworkwas scored using PCR-based restriction
fragment length polymorphisms (RFLP) for erbB2 and lgl2 or by
sequencing for erbB3b. The mutation in lgl2 causes an artificial
restrictionsiteforSfcI.ThemutationinerbB2causesalossofaBsrGI
restriction site.Treatment ofPCR productsfrom individualgenomic
samples with either SfcI or BsrGI leads to a genotype specific DNA
band pattern in agarose gel electrophoresis. The erbB3b mutation
was scored by sequencing of a PCR product spanning the site of
lesion. The nature of the mutation is a cytosine to adenine
transversion leading to a premature stop codon after 156bp.
Found at: doi:10.1371/journal.pgen.1000720.s003 (0.66 MB TIF)
Figure S4 Inhibition of erbB signaling does not restore
hemidesmosome formation in pen/lgl2 mutants. pen/lgl2 mutant
basal cells are unable to form hemidesmosomes, even after
inhibition of ErbB signaling. EM cross section through larval skin
5dpf reveals hemidesmosome formation at the basal membrane in
wild types (A, arrows) whereas pen/lgl2 mutants (B) and pen/lgl2
mutants treated with ErbB inhibitor PD168393 (C) lack these
structures.
Found at: doi:10.1371/journal.pgen.1000720.s004 (1.58 MB TIF)
Table S1 Expression profile of pen/lgl2 compared to wild type.
Using microarray technique the expression profile of wild-type
versus mutant zebrafish larval tails, posterior to the anal opening
was analysed. A significance threshold of adj. p-value of 10
26
(FDR) resulted in 117 genes to be significantly differentially
expressed. Within those, most prominent genes, involved in EMT
and cell cycle, as well as cytoskeleton rearrangements, can be
found. Additionally, genes involved in the formation of tight and
adherens junctions are present. The down-regulated genes are
indicated in red in this table whereas up-regulated genes are
indicated in black.
Found at: doi:10.1371/journal.pgen.1000720.s005 (0.03 MB
XLS)
Table S2 Comparison of phenotypes and genotypes in erbB2,lgl2
double mutant incrosses. Percental distribution of epidermal
neoplasia in pen/lgl2 single- and lgl2,erbB2 double mutants. Note
that the loss of erbB2 strongly reduces the formation of the
characteristic overgrowth phenotype in the pen/lgl2 mutant
background, even at late time points.
Found at: doi:10.1371/journal.pgen.1000720.s006 (0.03 MB
DOC)
Video S1 Phenotype of basal epidermal cells in the wild-type
larvae. A 90-minute timelapse movie of tg(Np63::Gal4,UAS::GFP)
wild-type zebrafish larva at 5dpf. Settings: 2061-min interval, 10
frames per second. The GFP labelled basal epidermal cells in the
wild-type larvae remain static.
Found at: doi:10.1371/journal.pgen.1000720.s007 (1.81 MB
MOV)
Video S2 Phenotype of basal epidermal cells in the pen/lgl2
mutants larvae. A 90-minute timelapse movie of tg(Np63::
Gal4,UAS::GFP) lgl2
2/2 zebrafish larva at 5dpf. Settings: 2061-
min interval, 10 frames per second. The GFP labelled basal
epidermal cells exhibit migratory behavior in the mutant larvae.
Cells show cell shape changes and development of lamellipodia
like cell protrusions, indicating their mesenchymal character.
Found at: doi:10.1371/journal.pgen.1000720.s008 (6.63 MB
MOV)
Video S3 Phenotype of basal epidermal cells in wild-type larvae.
A 240-minute timelapse movie of tg(DNp63::Gal4,UAS::GFP) wild-
type zebrafish larva at 5 dpf. Settings: 2561-min interval, 10
frames per second. The GFP labelled basal epidermal cells remain
static in the wild-type larvae.
Found at: doi:10.1371/journal.pgen.1000720.s009 (9.33 MB
MOV)
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larvae. A 240-minutes timelapse movie of tg(Np63::Gal4,UAS::GFP)
lgl2
2/2 zebrafish larva at 5dpf. Settings: 2561-min interval, 10
frames per second. The GFP labeled basal epidermal cells exhibit
migratory properties in the mutant larva. Cells show cell shape
changes and formation of lamellipodia like cell protrusions
indicating their mesenchymal character.
Found at: doi:10.1371/journal.pgen.1000720.s010 (13.28 MB
MOV)
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